Castry M. et al.
Cost-effectiveness of hepatitis C virus test-and-treat and risk reduction strategies among men who have sex with men living with HIV in France.
J. Int. AIDS Soc. 2022 Dec 25
Delavy M. et al.
A clinical study provides the first direct evidence that interindividual variations in fecal β-lactamase activity affect the gut mycobiota dynamics in response to β-lactam antibiotics.
mBio 2022 Nov 30
Rondinaud E. et al.
Acquisition of enterobacterales carrying the colistin resistance gene mcr following travel to the tropics.
J. Travel. Med. 2022 Nov 29
Belhadi D. et al.
The number of cases, mortality and treatments of viral hemorrhagic fevers: A systematic review.
PLoS Negl. Trop. Dis. 2022 Oct 31
Magréault S. et al.
Automated HPLC-MS/MS assay for the simultaneous determination of ten plasma antibiotic concentrations.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2022 Oct 9
Patrier J. et al.
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults.
Crit. Care 2022 Oct 3
Ghosn J. et al.
Prevalence of post-acute COVID-19 symptoms twelve months after hospitalisation in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.Clin. Microbiol. Infect.​ 2022 Sep 30
Bidet P. et al.
Epidemiological investigation of Pseudomonas aeruginosa isolates including multidrug-resistant serogroup O12 isolates, by use of a rapid and simplified multiple-locus variable-number of tandem repeats analysis and whole genome sequencing.J. Hosp. Infect. 2022 Sep 29
Caméléna F. et al.
Detection of Klebsiella pneumoniae isolates coproducing the plasmid-encoded 16S rRNA methyltransferase RmtF and carbapenemase in Paris, France.
Int. J. Antimicrob. Agents​ 2022 Sep
Marlin R. et al.
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
Nat. Commun.​ 2022 Aug 30
Sibiude J. et al.
Update of perinatal HIV-1 transmission in France: zero transmission for 5482 mothers on continuous ART from conception and with undetectable viral load at delivery.
Clin. Infect. Dis. 2022 Aug 29
Mailhe M. et al.
Clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection: an observational cohort study.
Clin. Microbiol. Infect.​ 2022 Aug 23
Hobson CA. et al.
Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-avibactam: an evolutionary overview.
Antimicrob. Agents Chemother. 2022 Aug 18
Ferré VM. et al.
Detection of monkeypox virus in anorectal swabs from asymptomatic men who Have sex with men in a sexually transmitted infection screening program in Paris, France.
Ann. Intern. Med.​ 2022 Aug 16
Marin J. et al.
The population genomics of increased virulence and antibiotic resistance in human commensal Escherichia coli over 30 years in France.
Appl. Environ. Microbiol. 2022 Aug 9
Billard-Pomares T. et al.
Use of whole-genome sequencing to explore Mycobacterium tuberculosis complex circulating in a hotspot department in France.
Microorganisms. 2022 Aug 6
Vigué L. et al.
Deciphering polymorphism in 61,157 Escherichia coli genomes via epistatic sequence landscapes.
Nat. Commun.​ 2022 Jul 12
Walter T. et al.
Extended prone positioning duration for COVID-19-related ARDS: benefits and detriments.
Crit. Care 2022 Jul 8
Habib A. et al.
Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan.
PLoS One 2022 Jul 8
Hobson CA. et al.
MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment.
JAC Antimicrob. Resist. 2022 Jul 5
Belan M. et al.
SARS-CoV-2 Exposures of Healthcare Workers from Primary Care, Long-Term Care Facilities and Hospitals: A Nationwide Matched Case-Control Study.
Clin. Microbiol. Infect. 2022 Jun 28
Danjean M. et al.
Evaluation of the inoculum effect of new antibiotics against carbapenem-resistant Enterobacterales.
Clin. Microbiol. Infect. 2022 Jun 28
Claessens YE. et al.
Early chest CT-scan in emergency patients affected by community-acquired pneumonia is associated with improved diagnosis consistency.
Eur. J. Emerg. Med. 2022 Jun 28
Molina JM. et al.
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
Lancet HIV. 2022 Jun 27
Rybak al.
A 16 th century Escherichia coli draft genome associated with an opportunistic bile infection.
Commun. Biol. 2022 Jun 16
Rybak al.
Reassessing the Performance of the « Step-By-Step » Approach to Febrile Infants 90 Days of Age and Younger in the Context of the COVID-19 Pandemic: A Multicentric Retrospective Study.
Pediatr. Infect. Dis. J. 2022 Jun 15
Martin-Blondel G. et al.
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.
BMC Infect Dis. 2022 Jun 13
Ader F. et al.
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
Lancet Infect. Dis. 2022 Jun 1
Moussiegt A. et al.
Escherichia coli community-acquired meningitis in adults: a case series of 29 patients in France.
Clin. Microbiol. Infect. 2022 May 11
Tesson al.
Systematic and quantitative view of the antiviral arsenal of prokaryotes.
Nat. Commun. 2022 May 2
d’Humières al.
Contribution of Clinical Metagenomics to the Diagnosis of Bone and Joint Infections.
Front. Microbiol. 2022 Apr 21
Ghazali al.
The Response of Emergency Departments (EDs) to the COVID-19 Pandemic: The Experience of 5 EDs in a Paris-Based Academic Hospital Trust.
Qual. Manag. Health Care. 2022 Apr 4
Su al.
TisB Protein Protects Escherichia coli Cells Suffering Massive DNA Damage from Environmental Toxic Compounds.
mBio. 2022 Apr 2
Hobson al.
The interplay between anticancer challenges and the microbial communities from the gut.
Eur. J. Clin. Microbiol. Infect. Dis. 2022 Mar 30
Contejean al.
Antimicrobial stewardship in high-risk febrile neutropenia patients.
Antimicrob. Resist. Infect. Control. 2022 Mar 26
Denamur al.
Genome wide association study of Escherichia coli bloodstream infection isolates identifies genetic determinants for the portal of entry but not fatal outcome.
PLoS Genet. 2022 Mar 24
Rossi al.
Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses.
Infection. 2022 Mar 22
Lo al.
Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing.
Microbiol. Spectr. 2022 Mar 21
Le Hingrat al.
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates.
AIDS. 2022 Mar 8
Moby al.
Poor oral health and hygiene habits in patients with infective endocarditis and previously identified predisposing cardiac condition: A prospective cohort study.
J. Infect. 2022 Mar 2
Lingas al.
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
J. Antimicrob. Chemother. 2022 Mar 2
Congo-Ouedraogo al.
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018-2019.
J. Eur. Acad. Dermatol. Venereol. 2022 Feb 28
Royer G. et al.
Reduced chlorhexidine susceptibility is associated with tetracycline resistance tet genes in clinical isolates of Escherichia coli.
Antimicrob. Agents Chemother. 2022 Feb 28
Berthod D. et al.
Are there reasons behind high Handrub consumption? A French National in-depth qualitative assessment.
Antimicrob. Resist. Infect. Control. 2022 Feb 23
Leducq V. et al.
Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020.
Sci. Rep. 2022 Feb 20
Timsit J.F. et al.
Cefiderocol for the Treatment of Infections Due To Metallo-Beta-Lactamase-Producing Pathogens in the CREDIBLE-CR And APEKS-NP Phase 3 Randomized Studies.
Clin. Infect. Dis. 2022 Feb 11
Egloff C. et al.
Pregnant women’s perceptions of the COVID-19 vaccine: A French survey.
PLoS One 2022 Feb 7
Landman R. et al.
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.
Lancet HIV. 2022 Feb 1
Guyeux C. et al.
Connection between two historical tuberculosis outbreak sites in Japan, Honshu, by a new ancestral Mycobacterium tuberculosis L2 sublineage.
Epidemiol. Infect. 2022 Jan 19
de Lastours V. et al.
Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatment.
Int. J. Med. Microbiol. 2022 Jan 4
Choudhury A. et al.
High-throughput navigation of the sequence space.
New Front. and Appl. of Synth. Biology. 2022 Jan